Alentis Therapeutics AG clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1/2 | 2 | |
| Phase 2 | 1 |
Disease areas by active trials
Cervical Cancer (2) · Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Bladder Cancer (1) · Cholangiocarcinoma (1) · Colorectal Cancer (1) · Esophageal Cancer (1) · Head & Neck Cancer (1)
Get alerts when Alentis Therapeutics AG's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.